Sucampo Pharma Inc (SCMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 18,487 | 33,371 | 13,128 | 7,015 | 5,061 |
| Depreciation Amortization | 45,683 | 10,701 | 1,172 | 1,598 | 1,555 |
| Income taxes - deferred | -37,038 | -9,779 | 770 | -1,678 | -23,026 |
| Accounts receivable | -18,788 | -9,149 | 67 | -4,047 | 3,256 |
| Accounts payable and accrued liabilities | -2,772 | -1,723 | -3,437 | 2,242 | -1,453 |
| Other Working Capital | -32,840 | -14,671 | 40 | -11,538 | 1,531 |
| Other Operating Activity | 35,581 | 9,835 | 19,138 | 2,199 | 25,076 |
| Operating Cash Flow | $8,313 | $18,585 | $30,878 | $-4,209 | $12,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,250 | 35,841 | -12,803 | -2,887 | 4,931 |
| PPE Investments | -1,226 | -3,557 | -66 | -168 | -439 |
| Net Acquisitions | N/A | -161,187 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -3,000 |
| Other Investing Activity | 4,634 | -2,248 | 25,828 | -9,561 | -5,081 |
| Investing Cash Flow | $-1,842 | $-131,151 | $12,959 | $-12,616 | $-589 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 290,495 | 235,911 | N/A | 10,600 | N/A |
| Debt Repayment | -269,913 | -8,236 | -24,904 | -7,539 | -7,500 |
| Common Stock Issued | 6,214 | 5,751 | 9,151 | 7,643 | 331 |
| Common Stock Repurchased | N/A | -43,956 | N/A | -336 | -1,277 |
| Other Financing Activity | 43,737 | -40,129 | 340 | 213 | 0 |
| Financing Cash Flow | $70,533 | $149,341 | $-15,413 | $10,581 | $-8,446 |
| Exchange Rate Effect | 13,020 | -113 | -904 | -1,676 | -1,605 |
| Beginning Cash Position | 108,284 | 71,622 | 44,102 | 52,022 | 50,662 |
| End Cash Position | 198,308 | 108,284 | 71,622 | 44,102 | 52,022 |
| Net Cash Flow | $90,024 | $36,662 | $27,520 | $-7,920 | $1,360 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,313 | 18,585 | 30,878 | -4,209 | 12,000 |
| Capital Expenditure | -1,226 | -3,557 | -66 | -168 | -439 |
| Free Cash Flow | 7,087 | 15,028 | 30,812 | -4,377 | 11,561 |